Document is current

Any future updates will be listed below

Influence of continuous erythropoietin receptor activator (CERA) administration intervals on erythropoietic effect in hemodialysis patients

Crossref DOI link: https://doi.org/10.1186/s41100-016-0071-x

Published Online: 2016-11-02

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark